The Future of BioPharma blog provides timely coverage of news that directly impacts the business strategies of the biotech, pharmaceutical and medical device industries. In addition to news coverage, the Future of BioPharma blog features live event coverage from IIR's Biopharmaceutical and Healthcare division.
According to the FDA, Combination Product submissions to the FDA for approval continue to increase. According to the webpage, there were 329 submissions in 2008, which increased to 330 in 2009. Read more about the trends in combination products submissions to the FDA here.
Share this article with your social network, just click below to share now!
No comments :
Post a Comment